SRHGF(SRHGF)
SRHGF
No analyst ratings available
No analyst price targets available for SRHGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $293.45B | $316.83B | $334.45B | $359.98B |
| Low | $287.09B | $309.96B | $327.21B | $352.18B |
| High | $301.41B | $325.42B | $343.53B | $369.75B |
| EBITDA Avg | $29.24B | $31.57B | $33.33B | $35.87B |
| Low | $28.61B | $30.89B | $32.61B | $35.10B |
| High | $30.04B | $32.43B | $34.23B | $36.85B |
| EBIT Avg | $17.33B | $18.71B | $19.75B | $21.26B |
| Low | $16.95B | $18.30B | $19.32B | $20.80B |
| High | $17.80B | $19.22B | $20.29B | $21.84B |
| Net Income Avg | $8.88B | $9.75B | $10.27B | $11.03B |
| Low | $8.63B | $9.48B | $9.98B | $10.72B |
| High | $9.19B | $10.10B | $10.63B | $11.41B |
| EPS Avg | $16.31 | $17.91 | $18.86 | $20.25 |
| Low | $15.85 | $17.41 | $18.33 | $19.68 |
| High | $16.88 | $18.54 | $19.53 | $20.96 |
| Analysts (Rev / EPS) | 8 / 1 | 5 / 1 | 6 / 1 | 6 / 1 |